Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. (Q44532649)
Jump to navigation
Jump to search
scientific article published on 13 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. |
scientific article published on 13 February 2014 |
Statements
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study (English)
Olga Ochoa-Gondar
Frederic Gomez-Bertomeu
Enric Figuerola-Massana
Xavier Raga-Luria
Imma Hospital-Guardiola
13 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference